99 related articles for article (PubMed ID: 28478749)
1. Development of a risk stratification model for pharmaceutical care in HIV patients.
Morillo-Verdugo R; Martínez-Sesmero JM; Lázaro-López A; Sánchez-Rubio J; Navarro-Aznárez H; DeMiguel-Cascón M
Farm Hosp; 2017 May; 41(3):346-356. PubMed ID: 28478749
[TBL] [Abstract][Full Text] [Related]
2. [Status of the structure, process and outcoms of pharmaceutical care to HIV patient in Spain. Origen study].
Morillo-Verdugo R; Jiménez-Galán R; Ibarra Barrueta O; Martín Conde M; Margusino Framinan L; Illaro Uranga A
Farm Hosp; 2014 Apr; 38(2):89-99. PubMed ID: 24669892
[TBL] [Abstract][Full Text] [Related]
3. [Quality healthcare and pharmaceutical care practice indicators to HIV+ patient].
Martín Conde MT; Monte Boquet E; Morillo Verdugo R
Farm Hosp; 2013; 37(4):276-85. PubMed ID: 24010688
[TBL] [Abstract][Full Text] [Related]
4. Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study.
Cantillana-Suárez MG; Robustillo-Cortés MLA; Gutiérrez-Pizarraya A; Morillo-Verdugo R
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e157-e163. PubMed ID: 33627478
[TBL] [Abstract][Full Text] [Related]
5. Simplification and Multidimensional Adaptation of the Stratification Tool for Pharmaceutical Care in People Living With HIV.
Morillo-Verdugo R; Aguilar Pérez T; Gimeno-Gracia M; Rodríguez-González C; Robustillo-Cortes MLA;
Ann Pharmacother; 2023 Feb; 57(2):163-174. PubMed ID: 35707861
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms.
Bernardez B; Mangues-Bafalluy I; Callejo VM; Ávila JJF; Rodríguez JAM; Aradilla MAP; Bautista MJM
Farm Hosp; 2024; 48(3):T108-T115. PubMed ID: 38461113
[TBL] [Abstract][Full Text] [Related]
7. Correlates of one-year mortality among patients living with HIV according to the stratification level of the pharmaceutical care model.
Contreras-Macías E; Robustillo-Cortés MLA; Morillo-Verdugo R
Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):302-307. PubMed ID: 37394400
[TBL] [Abstract][Full Text] [Related]
8. Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model.
Morillo Verdugo R; Villarreal Arevalo AL; Alvarez De Sotomayor M; Robustillo Cortes ML
Farm Hosp; 2016 Nov; 40(n06):544-568. PubMed ID: 27894228
[TBL] [Abstract][Full Text] [Related]
9. [Survey of the pharmaceutical care situation of the HIV patient in Spain].
Ibarra Barrueta O; Ortega Valín L;
Farm Hosp; 2008; 32(3):170-7. PubMed ID: 18840347
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms.
Bernardez B; Mangues-Bafalluy I; Callejo VM; Ávila JJF; Rodríguez JAM; Aradilla MAP; Bautista MJM
Farm Hosp; 2024; 48(3):108-115. PubMed ID: 37884399
[TBL] [Abstract][Full Text] [Related]
11. HIV Patients' Satisfaction with Pharmaceutical Care at a Nigerian Tertiary Healthcare Facility During the Covid-19 Pandemic.
Ahmad DM; Abonyi EE; Chukwudi Ugwuonah J; Okon PE; Aliyu S; Uzairue Bmls MSc LI; Lucero-Prisno DE
J Int Assoc Provid AIDS Care; 2023; 22():23259582231159093. PubMed ID: 36862608
[No Abstract] [Full Text] [Related]
12. Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.
Domingues EA; Ferrit-Martín M; Calleja-Hernández MÁ
Int J Clin Pharm; 2017 Feb; 39(1):52-60. PubMed ID: 27864732
[TBL] [Abstract][Full Text] [Related]
13. [Health care models for patients with multiple chronic conditions and the role of the hospital pharmacy/the hospital pharmacist].
Santos-Ramos B; Otero López MJ; Galván-Banqueri M; Alfaro-Lara ER; Vega-Coca MD; Nieto-Martín MD; Ollero-Baturone M
Farm Hosp; 2012; 36(6):506-17. PubMed ID: 23461444
[TBL] [Abstract][Full Text] [Related]
14. Qatar pharmacists' understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care.
El Hajj MS; Al-Saeed HS; Khaja M
Int J Clin Pharm; 2016 Apr; 38(2):330-43. PubMed ID: 26758716
[TBL] [Abstract][Full Text] [Related]
15. The challenge of aging and pharmacoterapeutic complexity in the HIV + patient.
Morillo-Verdugo R; Blanco Ramos JR; Abdel-Kader Martín L; Álvarez de Sotomayor M
Farm Hosp; 2018 May; 42(3):120-127. PubMed ID: 29730983
[TBL] [Abstract][Full Text] [Related]
16. Exploring example models of cross-sector, sessional employment of pharmacists to improve medication management and pharmacy support in rural hospitals.
Tan AC; Emmerton LM; Hattingh L; La Caze A
Rural Remote Health; 2015; 15(4):3441. PubMed ID: 26613289
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of factors associated with patients' comprehension of treatment at the start of antiretroviral therapy].
Braga Ceccato Md; Acurcio Fde A; Vallano A; Comini César C; Crosland Guimarães MD
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):7-13. PubMed ID: 19217997
[TBL] [Abstract][Full Text] [Related]
18. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
Robinson JD; Segal R; Lopez LM; Doty RE
Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
[TBL] [Abstract][Full Text] [Related]
19. HIV/AIDS patient's satisfactory and their expectations with pharmacy service at specialist antiretroviral therapy (ART) units.
Karunamoorthi K; Rajalakshmi M; Babu SM; Yohannes A
Eur Rev Med Pharmacol Sci; 2009; 13(5):331-9. PubMed ID: 19961038
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical care for HIV patients on directly observed therapy.
Foisy MM; Akai PS
Ann Pharmacother; 2004 Apr; 38(4):550-6. PubMed ID: 14990778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
